Year |
Citation |
Score |
2009 |
Li YT, Kwon YM, Spangrude GJ, Liang JF, Chung HS, Park YJ, Yang VC. Preliminary in vivo evaluation of the protein transduction domain-modified ATTEMPTS approach in enhancing asparaginase therapy. Journal of Biomedical Materials Research. Part A. 91: 209-20. PMID 18814276 DOI: 10.1002/Jbm.A.32204 |
0.499 |
|
2008 |
Kwon YM, Li Y, Naik S, Liang JF, Huang Y, Park YJ, Yang VC. The ATTEMPTS delivery systems for macromolecular drugs. Expert Opinion On Drug Delivery. 5: 1255-66. PMID 18976135 DOI: 10.1517/17425240802498059 |
0.656 |
|
2008 |
Kwon YM, Li YT, Liang JF, Park YJ, Chang LC, Yang VC. PTD-modified ATTEMPTS system for enhanced asparaginase therapy: a proof-of-concept investigation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 130: 252-8. PMID 18652856 DOI: 10.1016/J.Jconrel.2008.06.017 |
0.634 |
|
2003 |
Park YJ, Liang JF, Song H, Li YT, Naik S, Yang VC. ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects. Advanced Drug Delivery Reviews. 55: 251-65. PMID 12564979 DOI: 10.1016/S0169-409X(02)00181-3 |
0.656 |
|
2002 |
Liang JF, Li YT, Song H, Park YJ, Naik SS, Yang VC. ATTEMPTS: a heparin/protamine-based delivery system for enzyme drugs. Journal of Controlled Release : Official Journal of the Controlled Release Society. 78: 67-79. PMID 11772450 DOI: 10.1016/S0168-3659(01)00484-9 |
0.662 |
|
2001 |
Liang JF, Park YJ, Song H, Li YT, Yang VC. ATTEMPTS: a heparin/protamine-based prodrug approach for delivery of thrombolytic drugs. Journal of Controlled Release : Official Journal of the Controlled Release Society. 72: 145-56. PMID 11389993 DOI: 10.1016/S0168-3659(01)00270-X |
0.584 |
|
2000 |
Liang JF, Li YT, Connell ME, Yang VC. Synthesis and characterization of positively charged tPA as a prodrug using heparin/protamine-based drug delivery system. Aaps Pharmsci. 2: E7. PMID 11741223 DOI: 10.1208/ps020107 |
0.534 |
|
2000 |
Liang JF, Li YT, Yang VC. A novel approach for delivery of enzyme drugs: preliminary demonstration of feasibility and utility in vitro. International Journal of Pharmaceutics. 202: 11-20. PMID 10915922 DOI: 10.1016/S0378-5173(00)00414-2 |
0.565 |
|
2000 |
Liang JF, Li YT, Yang VC. Biomedical application of immobilized enzymes. Journal of Pharmaceutical Sciences. 89: 979-90. PMID 10906721 DOI: 10.1002/1520-6017(200008)89:8<979::AID-JPS2>3.0.CO;2-H |
0.444 |
|
2000 |
Liang JF, Song H, Li YT, Yang VC. A novel heparin/protamine-based pro-drug type delivery system for protease drugs. Journal of Pharmaceutical Sciences. 89: 664-73. PMID 10756332 DOI: 10.1002/(SICI)1520-6017(200005)89:5<664::AID-JPS12>3.0.CO;2-9 |
0.581 |
|
2000 |
Liang JF, Li Y, Yang VC. The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation. Thrombosis Research. 97: 349-58. PMID 10709911 DOI: 10.1016/S0049-3848(99)00188-7 |
0.509 |
|
Show low-probability matches. |